New Injectable Treatment for Obesity and Overweight

New Injectable Treatment for Obesity and Overweight

Many people across the world are obese or overweight. These conditions can cause health problems, such as high blood pressure, CVDs, diabetes, and cancerous conditions. Recently, the NICE has recommended a new injection for chronic weight management in the United Kingdom. Nevertheless, the regulating authorities have still not fully approved this treatment, although it was already tested in a trial.

The FDA has already approved this type of treatment with semaglutide injection. The medication mimics the hormone which the body releases after consuming food. Individuals who underwent this treatment had reduced appetite and hunger. Today, many people take appetite suppressants for the same purpose.

The trial included adult people with a body mass index higher than 30. The participants injected themselves with 2.4 mg of semaglutide or a placebo every week. Two-thirds underwent injectable treatment with semaglutide, and one-third with placebo. This trial was double-blind, meaning that neither the participants nor the researchers knew which treatment the participants received.

The findings indicate that the individuals in the first group lost nearly 15% of their weight. On the other hand, the individuals who received a placebo lost about 2.4% of their body mass. Furthermore, the research team identified undesirable effects in the participants of both groups, for instance, diarrhea, dyspepsia, and accumulation of gas in the alimentary canal. However, even though the participants experienced such consequences, they all went forward with the treatment.

Scientists advise that only certain obese individuals should undergo treatment with semaglutide. As per the NICE recommendations, the medication should be prescribed only for those with a body mass index higher than 35 who suffer from at least one medical condition caused by being overweight. Furthermore, this medication must be prescribed by a specialist. Also, the patients must follow a weight-loss program and are not allowed to take the drug longer than two years.

Yet, once the participants in the trial stopped the injections, they regained (most) of the weight they lost. The question of whether this injectable treatment is a permanent solution for people who want to reduce their weight remains unanswered.

Photo by cottonbro from Pexels

Leave a Comment

Your email address will not be published. *